Regency Centers director granted 428 shares in fees
Regency Centers Corp director Karin Klein reported a stock-based compensation grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Regency Centers Corp director Karin Klein reported a stock-based compensation grant. On February 4, 2026, she acquired 428 shares of Regency Centers common stock, reported at a price of $0.00 per share, as director fees paid in stock under Regency's Omnibus Incentive Plan.
Following this grant, Klein beneficially owns 23,198 shares of Regency Centers common stock in direct ownership form. The filing reflects a routine equity compensation award rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 428 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Karin Klein report for REG on February 4, 2026?
What is the nature of the equity award reported by Karin Klein in the REG Form 4?
Does Karin Klein’s REG Form 4 include any derivative securities transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.